In this webinar we'll unveil the latest breakthroughs in AI modeling for evaluating and optimizing vector designs to reduce discovery timelines from years to weeks! Discover how Resilience and Form Bio teamed up to apply cutting-edge in silico techniques, accelerating the vector design process, while producing a safer and more manufacturable vector.
Register Now
Rational vector design by selecting optimal vector element combinations
De-risking vector design and development with AI-optimized coding sequences for GOIs to enhance manufacturability
Anusha is the Lead of Life Sciences Insights at Form Bio. She brings experience working with top pharma companies and has deep understanding of US and EU drug regulatory pathways. Previously, she worked at Decisive identifying key market trends to meet client needs. Anusha was a Postdoctoral Fellow at UT Austin, where she worked on the DNA damage response, she holds a PhD in Molecular Medicine from The University of Gottingen.
Angela Anderson is the Senior Director of Strategic Growth at Form Bio. With over a decade of experience in the genomics and medtech industries, she has driven global market share and revenue growth within the healthcare and life sciences sectors. Previously, Angela held leadership roles as Director of Life Sciences at Viz.ai and Director of Global Marketing at DNAnexus. She holds a BS in Biology from Cal Poly, San Luis Obispo, and an MBA from San Francisco State University.
